Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,139
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,799
Class I recallsReasonable probability of serious health consequences
24,349
Class II recallsTemporary or medically reversible health consequences
2,891
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1

Showing 12,141–12,160 of 22,149 recalls

FDA Recall United States Terminated Historical recordClass I

Hy-Vee Stores Inc

Product
HyVee brand Pumpkin-flavored Bettercreme cheese cakes packag…
Reason
Product contained an ingredient that tested positive for Salmonella.
Published
February 13, 2019
Distribution
Distributed to consumers in Iowa, Illino…

View recall →

FDA Recall United States Terminated Historical recordClass I

Hy-Vee Stores Inc

Product
HyVee brand Golden Oreo-flavored cheese cakes packaged in th…
Reason
Product contained an ingredient that tested positive for Salmonella.
Published
February 13, 2019
Distribution
Distributed to consumers in Iowa, Illino…

View recall →

FDA Recall United States Terminated Historical recordClass I

Hy-Vee Stores Inc

Product
HyVee brand Smores-flavored Bettercreme cheese cakes package…
Reason
Product contained an ingredient that tested positive for Salmonella.
Published
February 13, 2019
Distribution
Distributed to consumers in Iowa, Illino…

View recall →

FDA Recall United States Terminated Historical recordClass I

Hy-Vee Stores Inc

Product
HyVee brand Pumpkin-fluff -flavored cheese cakes packaged in…
Reason
Product contained an ingredient that tested positive for Salmonella.
Published
February 13, 2019
Distribution
Distributed to consumers in Iowa, Illino…

View recall →

FDA Recall United States Terminated Historical recordClass I

Hy-Vee Stores Inc

Product
HyVee brand Oreo-flavored cheese cakes packaged in the follo…
Reason
Product contained an ingredient that tested positive for Salmonella.
Published
February 13, 2019
Distribution
Distributed to consumers in Iowa, Illino…

View recall →

FDA Recall United States Terminated Historical recordClass I

Funky Chunky LLC

Product
Nutty Choco Pop, 10 oz. bag. Sold in the following configur…
Reason
Nutty Choco Pop has in incorrect label and does not declare that it contains cashews and almonds.
Published
February 13, 2019
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Pizza Blends, LLC

Product
The Great American by Pizza Blends, Pizza Dough Mix With Yea…
Reason
The firm received an ingredient from their supplier that is potentially contaminated with Salmonella.
Published
February 13, 2019
Distribution
Distributed to customers in AR, CO, FL,…

View recall →

FDA Recall Terminated Historical recordClass II

Fexofenadine HCl Tablets, USP, 180 mg, packaged in a) 30-count bottles (NDC 0378-0782-93) and b) 500-count bottles (NDC 0378-0782-05); Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.

by Mylan Pharmaceuticals Inc.

Reason
Failed Impurities/Degradation Specifications: Related compound results obtained during routine stability testing was slightly elevated above specification.
Published
February 6, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

BromSite (bromfenac ophthalmic solution) 0.075%, 5 mL bottles, Rx Only, Distributed by : Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 49708-754-41

by Sun Pharmaceutical Industries, Inc.

Reason
Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.
Published
February 6, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

GENTAMICIN OPTH-SOL 5ml Compare: Garamycin. 5-mL plastic dropper bottle, Mfg: AKORN 17478-0283-10. NDC 52959-0103-00

by H J Harkins Company Inc dba Pharma Pac

Reason
Presence of Particulate Matter: Crystalline particles were noticed by manufacturer at the 24 month clarity testing.
Published
February 6, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Gentamicin Sulfate Ophthalmic Solution, USP 0.3%, 5 mL dropper bottle, Rx Only, Manufactured by: Akorn, Inc. Lake Forest, IL 60045, NDC 17478-283-10

by Akorn, Inc.

Reason
Presence of Particulate Matter: Crystalline particles were noticed at the 24 month clarity testing.
Published
February 6, 2019
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Irbesartan and Hydrochlorothiazide Tablets, USP 150/12.5 mg Rx 30 Tablets Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 NDC 43547-330-03

by Prinston Pharmaceutical Inc

Reason
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published
February 6, 2019
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 90 count NDC 43547-331-09

by Prinston Pharmaceutical Inc

Reason
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published
February 6, 2019
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 30 count - NDC 43547-331-03

by Prinston Pharmaceutical Inc

Reason
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published
February 6, 2019
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Irbesartan and HydrochlorothiazideTablets, USP 150/12.5 mg Rx Only 90 count Manufactured by: Zhejiang Huahai Pharmaceutical Co., Xunqiao, Linhai, Zhejiang 317024 China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 NDC 43547-330-09

by Prinston Pharmaceutical Inc

Reason
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published
February 6, 2019
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Irbesartan Tablets 300 mg 90 count Rx only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Xunqiao, Linhai, Zhejiang 317024 China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 NDC 43547-376-09

by Prinston Pharmaceutical Inc

Reason
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published
February 6, 2019
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Jac Vandenberg Inc.

Product
Plums sold at ALDI, packaged in a 2-pound bag with the brand…
Reason
Product may be contaminated with Listeria monocytogenes.
Published
February 6, 2019
Distribution
Alabama, California, Georgia, Illinois,…

View recall →

FDA Recall United States Terminated Historical recordClass I

Jac Vandenberg Inc.

Product
Nectarines sold as a bulk retail item, with PLU 3035 (white…
Reason
Product may be contaminated with Listeria monocytogenes.
Published
February 6, 2019
Distribution
Alabama, California, Georgia, Illinois,…

View recall →

FDA Recall United States Terminated Historical recordClass I

Jac Vandenberg Inc.

Product
Peaches, sold as a bulk retail item, with PLU 4044, and coun…
Reason
Product may be contaminated with Listeria monocytogenes.
Published
February 6, 2019
Distribution
Alabama, California, Georgia, Illinois,…

View recall →

FDA Recall Terminated Historical recordClass II

Fluocinolone Acetonide Topical Solution, USP, 0.01 %, 60 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202; Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873; NDC 43386-069-60.

by LUPIN SOMERSET

Reason
Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient.
Published
January 30, 2019
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.